Apremilast for genital erosive lichen planus in women (the AP-GELP Study): study protocol for a randomised placebo-controlled clinical trial

Abstract Background Genital erosive lichen planus (GELP) is a genital subtype of lichen planus, a chronic autoimmune inflammatory disease of unknown aetiology. In women, GELP is characterised by painful vulvo-vaginal mucosal erosions and scarring, often resulting in poor sexual health and reduced qu...

Full description

Bibliographic Details

Main Authors:	Kristin Helene Skullerud, Petter Gjersvik, Are Hugo Pripp, Erik Qvigstad, Anne Lise Ording Helgesen
Format:	Artigo
Language:	Inglês
Published:	BMC 2021-07-01
Series:	Trials
Subjects:	Genital erosive lichen planus Vulval disease Apremilast Phosphodiesterase-4 inhibitor Randomised clinical trial
Online Access:	https://doi.org/10.1186/s13063-021-05428-w
Tags:	Add Tag No Tags, Be the first to tag this record!